0001104659-24-024196.txt : 20240214 0001104659-24-024196.hdr.sgml : 20240214 20240214201939 ACCESSION NUMBER: 0001104659-24-024196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Yong Man CENTRAL INDEX KEY: 0001991122 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40427 FILM NUMBER: 24641631 MAIL ADDRESS: STREET 1: NKGEN BIOTECH, INC. STREET 2: 3001 DAIMLER STREET CITY: SANTA ANA STATE: CA ZIP: 92705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NKGen Biotech, Inc. CENTRAL INDEX KEY: 0001845459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3001 DAIMLER ST, CITY: SANTA ANA STATE: CA ZIP: 92705 BUSINESS PHONE: (949) 396-6830 MAIL ADDRESS: STREET 1: 3001 DAIMLER ST, CITY: SANTA ANA STATE: CA ZIP: 92705 FORMER COMPANY: FORMER CONFORMED NAME: Graf Acquisition Corp. IV DATE OF NAME CHANGE: 20210210 4 1 tm246293-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-12 0 0001845459 NKGen Biotech, Inc. NKGN 0001991122 Kim Yong Man NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705 0 1 0 0 CSO and CIO 0 Stock Option (right to buy) 1.62 2024-02-12 4 A 0 75000 0.00 A Common Stock 75000 75000 D On February 12, 2024, the reporting person was granted 75,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in equal installments on the first of each month, beginning October 1, 2023, and ending October 1, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. /s/ Yong Man Kim 2024-02-14